COMP <GO>
COYA vs CING // NET PROFIT MARGIN
Coya Therapeutics Inc. (NASDAQ) VS. Cingulate Inc. (NASDAQ) • 15-METRIC TALLY: COYA 3
— CING 1
■ METRIC PARITY
LAST: $3.11 (-3.71%) • MKT CAP: $75.8M
net-margins
-60.00%
LAST: $4.72 (-6.16%) • MKT CAP: $73.1M
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COYA VS. CING)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COYA | CING | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.50% | -23.06% | +11.56 | COYA | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 123.60% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.08 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | COYA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 22.0 | 53.1 | -31.10 | CING | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $75.8M | $73.1M | $2.6M | COYA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COYA REV | CING REV | COYA GROSS % | CING GROSS % | COYA FCF | CING FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.9M | $55.8M | — | — | -$10.7M | -$17.4M |
| FY 2024 | $3.6M | $43.8M | — | — | -$10.3M | -$18.7M |
| FY 2023 | $6.0M | $63.7M | — | — | -$11.2M | -$15.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COYA // BETA —
CING // BETA —